"We are both proud and humble to have Knight Therapeutics Inc. once again featured on the Globe and Mail's Report on Canada's Women Lead Here, as one of the top companies for executive gender ...

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

President Trump's proposed tariffs on Irish pharmaceutical imports aim to boost US production but may ultimately harm ...

Proposed US tariffs on pharmaceutical exports will damage the economic prospects of US companies in Ireland, the Irish ...

The new recipients of 23andMe’s data would not necessarily have to offer consumers the ability to opt out once they take possession of it. And it remains unclear which (or how many) hands the data ...

Value stocks aren't typically the most exciting investments, but they can often provide steady capital gains without causing investors to lose any sleep during periods of market volatility.

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02. A ...

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

Over a month into Robert F. Kennedy Jr.’s tenure as HHS Secretary, leaders in pharma, medical marketing and media circles are ...

A Dundee academic has been awarded a prestigious national prize for his work on neurodegenerative diseases, including ...

US manufacturers are increasingly nervous about President Trump’s tariffs. They’re already disrupting supply chains, and the ...

German airline Lufthansa's air freight business said on Friday it is experiencing an increase in demand for pharmaceutical ...